Viewing Study NCT06700603


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-28 @ 4:37 AM
Study NCT ID: NCT06700603
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-11-22
First Post: 2024-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Second-line Irinotecan Liposome Combination Regimen for Irinotecan-treated Pancreatic Cancer
Sponsor: Rui-hua Xu, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module